Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy

Hepatology

Volumn 34, Issue 2, 2001, Pages 283-287

  Benhamou, Yves ^a   Di Martino, Vincent ^a   Bochet, Marie ^a   Colombet, Geneviève ^a   Thibault, Vincent ^a   Liou, Amélie ^a   Katlama, Christine ^a   Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0034917518     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26517     Document Type: Article

References (27)

1. Prevalence of antibodies to hepatitis C virus in patients infected with the human immunodeficiency virus
2. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels
3. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
6. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
7. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
8. Severe hepatitis in three AIDS patients treated with indinavir
9. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir
10. Indinavir-associated hepatitis in patients with advanced HIV infection
11. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy
12. Acute hepatitis in HIV-infected patients during ritonavir treatment
13. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
14. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy
15. Natural history of liver fibrosis progression in patients with chronic hepatitis C
16. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C
17. An algorithm for the grading of activity in chronic hepatitis C
18. Traitement antirétroviraux
19. Traitement antirétroviral
20. Severe hepatic cytolysis: Incidence and risk factors in patients treated by antiretroviral combinations therapy Aquitaine Cohort, France, 1996-1998
21. Elevated liver enzymes following initiation of antiretroviral therapy
22. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens
23. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells
24. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
25. Association of circulating receptor FcyRIII-positive monocytes in AIDS patients with elevated levels of transforming grow factor-β
26. Cytokine production in saquinavir treated mice